One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-137574
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 1 |
Affiliation: Complejo Hospitalario de Salamanca, Medical College and Hospital, Kolkata, Dana-Farber Cancer Institute, Centre Hospitalier Universitaire de Nantes, King's College Hospital NHS Foundation Trust, Medical University of Silesia, Karyopharm Therapeutics (United States), Evangelismos Hospital, University of Alberta, Cherkasy State Technological University, National Cancer Institute, Norton Healthcare, National and Kapodistrian University of Athens, Centre Hospitalier Universitaire de Poitiers, University Hospitals of Leicester NHS Trust, Mount Sinai Medical Center, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, Indira Gandhi Institute of Medical Sciences, Institute of Cancer Research, University of Calgary, Centre Hospitalier Universitaire de Lille, University of Bologna, Texas Oncology, Charles University, University of Maryland, Baltimore, University Hospital Brno, Imperial College Healthcare NHS Trust, Alexandra Hospital, The University of Texas Southwestern Medical Center, City Clinical Hospital
Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
